AB Klaipėdos nafta (KN) will hold an Investor Conference Webinar to introduce KN long-term corporate strategy for 2023-2050

Written by Customer Service on June 9, 2023. Posted in Public Companies.

KN invites shareholders, investors, analysts, and other stakeholders to join its investor conference webinar scheduled on June 14th of 2023 at 9.00 am (EET). The presentation will be held in English. The webinar will be hosted by KN Chief Executive Officer Darius Šilenskis and Chief Financial Officer Mindaugas Kvekšas who will introduce new KN corporate strategy for the period of 2023-2050. How to join the webinar?To join the webinar, please register via following link: https://nasdaq.zoom.us/webinar/register/WN_Tv65DFNpQ5Gml_ffDtf0Ww You will be provided with the webinar link and instructions how to join successfully. When joining the webinar for the first time, you will be asked to download the plug-in which will take only few seconds. In case plug-in can’t be downloaded, a web browser which enables attending the webinar, opens...

Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2023 European Hematology Association Congress

Written by Customer Service on June 9, 2023. Posted in Public Companies.

Ongoing Phase 1b Dose-Escalation Study of Single-Agent Treatment with RVU120 in Patients with AML or High-Risk MDS Shows Clinical Benefit and Favorable Safety; Dose-Escalation Continues, Currently Enrolling at 175 mg; In vivo Data Show Synergistic Effects of RVU120 in Combination with Ruxolitinib in Myeloproliferative Neoplasms; KRAKOW, Poland, June 09, 2023 (GLOBE NEWSWIRE) — Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, today announced updated safety and efficacy data from the Phase 1b dose-escalation study of RVU120 in patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) and preclinical data of RVU120 in combination with the JAK1/2 inhibitor ruxolitinib (RUX) in...

Reliq Health Technologies, Inc. Announces Six New Contracts in CA, FL and NV

Written by Customer Service on June 9, 2023. Posted in Public Companies.

HAMILTON, Ontario, June 09, 2023 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has signed six new contracts with physician practices in California, Florida and Nevada. These new contracts are expected to add over 3,000 new patients to Reliq’s iUGO Care platform by the end of Q1 calendar year 2024, at an average revenue of $65 per patient per month. “We are very pleased with our continued traction in California, Florida and Nevada,” said Dr. Lisa Crossley, CEO at Reliq Health Technologies, Inc. “The southern US states are a particularly attractive market segment for Reliq due to demographics....

Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas at European Hematology Association (EHA) Annual Meeting 2023

Written by Customer Service on June 9, 2023. Posted in Public Companies.

Media Release COPENHAGEN, Denmark; June 9, 2023, at 9:00am CEST Results from phase 1/2 EPCORE™ NHL-2 trial investigating epcoritamab in combination with rituximab-lenalidomide (R2) showed a 98 percent overall response rate (ORR), 87 percent complete metabolic response (CMR) in patients with relapsed or refractory (R/R) follicular lymphoma (FL) Results from the EPCORE™ NHL-1 expansion cohort, including longer follow-up in challenging-to-treat large B-cell lymphoma (LBCL) patients, also presented First patients dosed in phase 3 EPCORE™ DLBCL-2 and phase 2 EPCORE™ DLBCL-3 trials demonstrates ongoing commitment to further evaluating epcoritamab Genmab A/S (Nasdaq: GMAB) today announced data from its ongoing phase 1/2 EPCORE™ NHL-2 trial investigating epcoritamab, a T-cell engaging bispecific antibody administered...

Successful Testing of Laser Scanner for ADAS and Autonomous Cars

Written by Customer Service on June 9, 2023. Posted in Public Companies.

The initial prototype of Terranet’s laser scanner, delivered to the office in Lund in March, has undergone successful testing in a controlled laboratory environment. The laser scanner serves as a vital component of the BlincVision anti-collision product, and this testing phase marks a significant milestone towards integrating the system into vehicles. The new laser scanner unit has been extensively and successfully tested in conjunction with the existing event camera technology. The scanner has demonstrated excellent performance by effectively detecting and visualizing objects within a range of 5 to 30 meters. The laboratory demonstration took place under indoor fluorescent lighting conditions. The laser scanner operated five near-infrared laser beams at a peak power of 60W total, and a repetition rate of 400kHz. “During the...

EUROCOMMERCIAL PROPERTIES N.V.: STOCK DIVIDEND ISSUE PRICE

Written by Customer Service on June 9, 2023. Posted in Public Companies.

Date: 9 June 2023 Release: Before opening of Euronext Please open the following link to read the full report including annexes: Attachment Full press release

The net asset value of EfTEN Real Estate Fund AS shares as of 31.05.2023

Written by Customer Service on June 9, 2023. Posted in Public Companies.

In May, EfTEN Real Estate Fund AS consolidated rental income was 2,554 thousand euros, i.e., 12 thousand euros more than in April. The rental income increased primarily due to rent indexations and turnover rents in companies owning shopping center properties. In May, the fund’s subsidiary entered into an agreement with the tenant of the Betoon 6 logistics center to expand the rental area of the building by 739.2 m2. After the construction works, the tenant will use 3184.2 m2 (18.5% of the total NLA of the building). The investment amounts to 956 thousand euros, which is financed by SEB Pank. According to the agreement, the rental yield of the investment is 8.5%. Interest expenses increased in May to 638 thousand euros (by 10 thousand euros). The fund’s weighted average interest rate in May was 5.13% (4.94% in April). All the...

Ad hoc announcement: GAM Holding AG confirms the publication of the offer prospectus of Liontrust

Written by Customer Service on June 9, 2023. Posted in Public Companies.

9 June 2023 PRESS RELEASE Ad hoc announcement pursuant to Art. 53 Listing Rules: GAM Holding AG confirms the publication of the offer prospectus of Liontrust Liontrust Asset Management PLc had previously stated that it intended to publish a Circular and the Offer Prospectus for the public exchange offer for all publicly held registered shares of GAM Holding AG on 9 June 2023. Liontrust Asset Management PLc now expects to publish both the Circular and Offer Prospectus on or around 13 June 2023. GAM is making this announcement pursuant to its obligations under Article 53 of the Listing Rules of the SIX Exchange. For further information please contact: Charles Naylor Head of Communications and Investor RelationsT +44 7890 386 699 Media Relations Ute Dehn Christen T +41 58 426 31 36 Visit us: www.gam.comFollow...

Mowi ASA (OSE: MOWI): 2023 Salmon Farming Industry Handbook

Written by Customer Service on June 9, 2023. Posted in Public Companies.

Please find attached the 2023 version of the Salmon Farming Industry Handbook. The handbook is also available on our website www.mowi.com. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Attachment 2023 Salmon Farming Industry Handbook

Dassault Systèmes’ Capital Markets Day: Doubling non-IFRS EPS by 2028 to €2.20 – €2.40, Announcing Pascal Daloz as Chief Executive Officer on January 1, 2024

Written by Customer Service on June 9, 2023. Posted in Public Companies.

Press ReleaseVELIZY-VILLACOUBLAY — June 9, 2023 Dassault Systèmes’ Capital Markets Day: Doubling non-IFRS EPS by 2028 to €2.20 – €2.40, Announcing Pascal Daloz as Chief Executive Officer on January 1, 2024 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) will host its 2023 Capital Markets Day at the Company’s headquarters in Vélizy-Villacoublay, France, today, June 9, 2023. The event, dedicated to investors, includes a discussion of the firm’s business, strategy and objectives for the next five years. Commencing at 7:00 AM New York time / 1:00 PM Paris time / 12:00 PM London time, the event will be webcast live and recorded. Both the live sessions and replays can be accessed via Dassault Systèmes’ investor website: https://investor.3ds.com/. The on-demand webcast of the event will be available from June 13, 2023. Today’s...

Year: 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice